Eric D. Marsh

12.8k total citations · 2 hit papers
165 papers, 5.9k citations indexed

About

Eric D. Marsh is a scholar working on Genetics, Cognitive Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Eric D. Marsh has authored 165 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 89 papers in Genetics, 75 papers in Cognitive Neuroscience and 52 papers in Psychiatry and Mental health. Recurrent topics in Eric D. Marsh's work include Genetics and Neurodevelopmental Disorders (86 papers), Epilepsy research and treatment (48 papers) and Autism Spectrum Disorder Research (44 papers). Eric D. Marsh is often cited by papers focused on Genetics and Neurodevelopmental Disorders (86 papers), Epilepsy research and treatment (48 papers) and Autism Spectrum Disorder Research (44 papers). Eric D. Marsh collaborates with scholars based in United States, Australia and United Kingdom. Eric D. Marsh's co-authors include Orrin Devinsky, Linda Laux, Elizabeth A. Thiele, Ian Miller, J. Helen Cross, Stephen Wright, Ingrid E. Scheffer, Rima Nabbout, D. G. Sale and Alan J. McComas and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Eric D. Marsh

152 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome

2017 1.2k citations Orrin Devinsky, Eric D. Marsh et al. profile →
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study

2023 106 citations Jeffrey L. Neul, Alan K. Percy et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric D. Marsh United States	37	2.0k	1.8k	1.7k	1.5k	1.2k	165	5.9k
Patrick Cras Belgium	52	2.1k 1.0×	968 0.6×	1.0k 0.6×	1.7k 1.1×	3.9k 3.2×	259	11.3k
Yasuomi Ouchi Japan	44	1.1k 0.5×	356 0.2×	1.7k 1.0×	1.9k 1.3×	1.1k 0.9×	146	7.1k
Kaarina Partanen Finland	49	3.0k 1.5×	720 0.4×	2.5k 1.5×	1.6k 1.1×	733 0.6×	142	7.9k
James W. Wheless United States	52	5.3k 2.6×	690 0.4×	3.5k 2.1×	2.2k 1.5×	761 0.6×	265	9.9k
Pasquale Striano Italy	52	5.1k 2.5×	2.7k 1.5×	700 0.4×	2.3k 1.6×	2.6k 2.1×	478	10.4k
Jerzy Węgiel United States	44	1.2k 0.6×	1.2k 0.7×	1.2k 0.7×	1.3k 0.9×	3.2k 2.6×	122	9.1k
João Pereira Leite Brazil	42	2.4k 1.2×	372 0.2×	1.3k 0.8×	3.7k 2.5×	1.5k 1.2×	199	6.5k
Maria Roberta Cilio United States	37	1.9k 1.0×	565 0.3×	679 0.4×	1.4k 0.9×	849 0.7×	73	4.3k
Berten Ceulemans Belgium	41	3.2k 1.6×	1.3k 0.8×	988 0.6×	1.6k 1.1×	1.5k 1.2×	155	5.5k
Luigi Murri Italy	45	1.4k 0.7×	241 0.1×	1.6k 1.0×	1.4k 0.9×	1.6k 1.3×	257	7.3k

Countries citing papers authored by Eric D. Marsh

Since Specialization

Citations

This map shows the geographic impact of Eric D. Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric D. Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric D. Marsh more than expected).

Fields of papers citing papers by Eric D. Marsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric D. Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric D. Marsh. The network helps show where Eric D. Marsh may publish in the future.

Co-authorship network of co-authors of Eric D. Marsh

This figure shows the co-authorship network connecting the top 25 collaborators of Eric D. Marsh. A scholar is included among the top collaborators of Eric D. Marsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric D. Marsh. Eric D. Marsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tomlinson, Samuel B., Benjamin C. Kennedy, & Eric D. Marsh. (2025). Co-activation of interictal epileptiform discharges localizes seizure onset zone and fluctuates with brain state. Brain Communications. 7(2). fcaf127–fcaf127. 1 indexed citations

Leonard, Helen, Eric D. Marsh, Scott Demarest, et al.. (2025). Content Validation of the Communication Inventory Disability–Observer Reported (CID-OR). Journal of Child Neurology. 41(4). 520–528.

Brimble, Elise, Pamela Ventola, Christopher E. Hart, et al.. (2025). Longitudinal characterization of clinical, developmental, and behavioral phenotypes in 101 children and adults with FOXG1 syndrome. Journal of Neurodevelopmental Disorders. 17(1). 64–64.

Percy, Alan K., Jeffrey L. Neul, Tim A. Benke, et al.. (2024). Trofinetide for the treatment of Rett syndrome: Results from the open-label extension LILAC study. Med. 5(9). 1178–1189.e3. 15 indexed citations

Percy, Alan K., Tim A. Benke, Eric D. Marsh, & Jeffrey L. Neul. (2024). Rett syndrome: The Natural History Study journey. SHILAP Revista de lepidopterología. 2(3). 189–205. 3 indexed citations

Percy, Alan K., Jeffrey L. Neul, Tim A. Benke, et al.. (2024). Trofinetide for the treatment of Rett syndrome: Long-term safety and efficacy results of the 32-month, open-label LILAC-2 study. Med. 5(10). 1275–1281.e2. 9 indexed citations

Saby, Joni N., Tim A. Benke, Sarika U. Peters, et al.. (2024). Electroencephalographic Correlates of Clinical Severity in the Natural history study of RTT and Related Disorders. Annals of Neurology. 96(1). 175–186. 5 indexed citations

Demarest, Scott, Peter Jacoby, Heather E. Olson, et al.. (2024). Modification of a parent-report sleep scale for individuals with CDKL5 deficiency disorder: a psychometric study. Journal of Clinical Sleep Medicine. 20(12). 1887–1893. 1 indexed citations

Olson, Heather E., Sam Amin, Nadia Bahi‐Buisson, et al.. (2023). Long‐term treatment with ganaxolone for seizures associated with cyclin‐dependent kinase‐like 5 deficiency disorder: Two‐year open‐label extension follow‐up. Epilepsia. 65(1). 37–45. 16 indexed citations

10.

Neul, Jeffrey L., Alan K. Percy, Tim A. Benke, et al.. (2023). Trofinetide Treatment Demonstrates a Benefit Over Placebo for the Ability to Communicate in Rett Syndrome. Pediatric Neurology. 152. 63–72. 13 indexed citations

11.

Reeve, Bryce B., Nicole Lucas, Dandan Chen, et al.. (2023). Validation of the Observer-Reported Communication Ability (ORCA) measure for individuals with Rett syndrome. European Journal of Paediatric Neurology. 46. 74–81. 4 indexed citations

12.

Zhou, Zhaolan, et al.. (2023). IRSF 2023 - Rett Syndrome Scientific Meeting Report. 6(4). 137–150. 1 indexed citations

13.

Percy, Alan K., Jeffrey L. Neul, Sarika U. Peters, et al.. (2023). Current Status of Developmental Encephalopathies: Rett Syndrome, MECP2 Duplication Disorder, CDKL5 Deficiency Disorder and FOXG1 Disorder. GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen). 6(3). 73–100.

14.

Ahrens‐Nicklas, Rebecca C., Luis Tecedor, Richard J. Chung, et al.. (2022). Neuronal genetic rescue normalizes brain network dynamics in a lysosomal storage disorder despite persistent storage accumulation. Molecular Therapy. 30(7). 2464–2473. 8 indexed citations

15.

Cuddapah, Vishnu Anand, Holly Dubbs, Laura Adang, et al.. (2021). Understanding the phenotypic spectrum of ASXL‐related disease: Ten cases and a review of the literature. American Journal of Medical Genetics Part A. 185(6). 1700–1711. 18 indexed citations

16.

Berecki, Géza, Katherine L. Helbig, Tyson L. Ware, et al.. (2020). Novel Missense CACNA1G Mutations Associated with Infantile-Onset Developmental and Epileptic Encephalopathy. International Journal of Molecular Sciences. 21(17). 6333–6333. 10 indexed citations

17.

Peters, Sarika U., Cary Fu, Eric D. Marsh, et al.. (2020). Phenotypic features in MECP2 duplication syndrome: Effects of age. American Journal of Medical Genetics Part A. 185(2). 362–369. 15 indexed citations

18.

Bonn‐Miller, Marcel O., Charles V. Pollack, David Casarett, et al.. (2019). Priority Considerations for Medicinal Cannabis-Related Research. Cannabis and Cannabinoid Research. 4(3). 139–157. 23 indexed citations

19.

Ng, Jessica M.Y., Daniel Martínez, Eric D. Marsh, et al.. (2015). Generation of a Mouse Model of Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System through Combined Deletion of Snf5 and p53. Cancer Research. 75(21). 4629–4639. 30 indexed citations

20.

Marsh, Eric D., et al.. (2007). Evaluation of Feature Selection Techniques for Analysis of Functional MRI and EEG.. 256–262. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact